Naturally acquired humoral immunity to the malarial parasite Plasmodium falciparum can protect against disease, although the precise mechanisms remain unclear. Although antibody levels can be measured by ELISA, few studies have investigated functional antibody assays in relation to clinical outcomes. In this study we applied a recently developed functional assay of antibody-mediated opsonisation of merozoites, to plasma samples from a longitudinal cohort study conducted in a malaria endemic region of Papua New Guinea (PNG). Phagocytic activity was quantified by flow cytometry using a standardized and high-throughput protocol, and was subsequently evaluated for association with protection from clinical malaria and high-density parasitemia. Opsonising antibody responses were found to: i) increase with age, ii) be enhanced by concurrent infection, and iii) correlate with protection from clinical episodes and high-density parasitemia. Stronger protective associations were observed in individuals with no detectable parasitemia at baseline. This study presents the first evidence for merozoite phagocytosis as a correlate of acquired immunity and clinical protection against P. falciparum malaria.
Opsonising Antibodies to P. falciparum Merozoites Associated with Immunity to Clinical Malaria
D. Hill,E. Eriksson,Connie S. N. Li Wai Suen,Chris Y. Chiu,Victoria Ryg-Cornejo,L. Robinson,P. Siba,I. Mueller,D. Hansen,L. Schofield
Published 2013 in PLoS ONE
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
PLoS ONE
- Publication date
2013-09-09
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-50 of 50 references · Page 1 of 1
CITED BY
Showing 1-96 of 96 citing papers · Page 1 of 1